Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Enhancing Neuronal Networks with <i>Rhinella schneideri</i> Skin Secretion Molecules: Implications for Neurodegenerative Disorders.

Toxins·2026

Same author

Human Dental Pulp Stem Cells Modulate Acute Inflammation Kinetics in the AIRmax Murine Model by Sustained TNF-Alpha Suppression and Transient Homing.

Cells·2026

Same author

A phase I, open-label study of intravenous human dental pulp stem cells (NestaCell®) at two dose levels in patients with Huntington's disease.

Stem cell research & therapy·2025

Same author

Impact of substrate choice on human osteoclast differentiation and secretome: Implications for targeted therapeutic development.

PloS one·2025

Same author

AI-Enhanced Transcriptomic Discovery of Druggable Targets and Repurposed Therapies for Huntington's Disease.

Brain sciences·2025

Same author

Phase II trial of intravenous human dental pulp stem cell therapy for Huntington's disease: a randomized, double-blind, placebo-controlled study.

Stem cell research & therapy·2025

Search research articles

Related Experiment Video

Updated: Feb 17, 2026

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

Cell-based technologies for Huntington's disease.

Mônica Santoro Haddad¹, Cristiane Valverde Wenceslau², Celine Pompeia²

¹MD. Faculdade de Medicina da Universidade de São Paulo - Neurologia São Paulo, São Paulo, SP, Brazil.

Dementia & Neuropsychologia

|December 8, 2017

Summary

This summary is machine-generated.

Stem cell therapies show promise for treating Huntington's disease (HD) by replacing neurons and preventing cell death. However, challenges remain regarding safety, transplantation procedures, and ethical considerations before clinical application.

Keywords:

Huntington's disease cell therapy safety issues stem cells

More Related Videos

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

Related Experiment Videos

Last Updated: Feb 17, 2026

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

High Content Screening in Neurodegenerative Diseases

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy

Published on: June 27, 2018

Area of Science:

Neuroscience
Regenerative Medicine
Genetics

Background:

Huntington's disease (HD) is a fatal, incurable genetic neurodegenerative disorder.
HD leads to progressive neuronal loss, causing severe physical and mental decline.

Purpose of the Study:

To review the potential of various stem cell types for Huntington's disease (HD) treatment.
To discuss the efficacy and challenges of stem cell transplantation in preclinical and clinical studies for HD.

Main Methods:

Review of studies utilizing human fetal tissue (hFT)-derived neural stem cells (NSCs), embryonic stem cells (ESCs), and induced pluripotent stem cells (IPSCs).
Inclusion of studies on mesenchymal stem cells (MSCs) derived from non-neural tissues for in vivo applications.
Analysis of cell grafting, differentiation into neurons, and behavioral improvements in HD models.

Main Results:

Stem cell transplantation demonstrated successful cell engraftment and differentiation into mature neurons in HD models.
Observed behavioral improvements in animal models following stem cell transplantation therapy.
Evidence supports the potential of stem cells for Huntington's disease transplantation therapy.

Conclusions:

Stem cell therapies hold significant promise for Huntington's disease treatment.
Safety concerns include teratogenicity of NSCs and pluripotent stem cells.
Transplantation procedure risks, and ethical/technical issues with fetal/embryonic cells require further investigation.